EU Pharma Probe Expected To Veer From FTC Course
While the European Commission appears to have taken a cue from the U.S. Federal Trade Commission in cracking down on potential antitrust issues and patent abuse in the pharmaceutical industry, the...To view the full article, register now.
Already a subscriber? Click here to view full article